Highlights
- Natco Pharma shares traded modestly higher during Tuesday's session.
- The stock remains significantly below its 52-week high recorded in May.
- One-month returns have lagged the broader Nifty 500 benchmark.
Natco Pharma Limited (NSE:NATCOPHARM) traded in positive territory on Tuesday, with the stock quoted at Rs 888.80, up Rs 4.20 or 0.51 percent from its previous close of Rs 884.30.
The stock opened at Rs 893.10 and touched an intraday high of Rs 913.40 before easing. The day's low stood at Rs 884.80, indicating volatility during the trading session.
Recent Performance Reflects Mixed Trends
Natco Pharma's performance across different periods presents a mixed picture. Over the past week, the stock gained 4.38 percent, outperforming the Nifty 500 index, which advanced 0.15 percent.
However, over the last month, the stock declined 24.01 percent, significantly underperforming the benchmark index's gain of 1.68 percent. On a year-to-date basis, Natco Pharma has delivered a marginal gain of 0.07 percent, compared with a decline of 3.67 percent in the Nifty 500.
Over a one-year period, the stock has risen 2.25 percent, slightly ahead of the benchmark's return of 0.13 percent. Longer-term returns show gains of 31.87 percent over three years, although this trails the Nifty 500 return of 43.85 percent. Over five years, the stock has declined 17.12 percent, while the benchmark gained 71.58 percent.
Trading Below Annual Peak
Natco Pharma reached its 52-week high of Rs 1,226.80 on May 12, 2026. The stock's 52-week low stands at Rs 789.00, recorded on September 30, 2025.
At the current market price of Rs 888.80, the stock is trading well below its annual high but remains above its 52-week low. The gap between the current price and the yearly peak highlights the correction witnessed in the stock during recent weeks.
Valuation Metrics Remain In Focus
Based on exchange data, Natco Pharma is trading at a price-to-earnings (P/E) ratio of 11.55. The adjusted P/E ratio also stands at 11.55.
The company's market capitalisation is approximately Rs 15,919.29 crore, while the free-float market capitalisation stands at Rs 7,951.86 crore.
Valuation metrics remain an important factor for investors assessing pharmaceutical companies, particularly in relation to earnings growth, product pipelines and market opportunities.
Trading Activity And Volatility
During the session, around 7.58 lakh shares changed hands, generating traded value of approximately Rs 68.34 crore.
The stock recorded an impact cost of 0.03, while annualised volatility stood at 48.72 percent, reflecting relatively higher price fluctuations compared with several large-cap counters. Deliverable quantity accounted for 40.22 percent of traded volume.
Pharmaceutical Sector Presence
Natco Pharma operates in the pharmaceutical industry and is a constituent of the Nifty Smallcap 100 index. The company is involved in the development and manufacturing of pharmaceutical products across various therapeutic segments.
Pharmaceutical stocks are often influenced by factors such as regulatory approvals, product launches, competition, export market trends and earnings performance.
Key Risks To Watch
- Regulatory actions may affect product approvals and sales.
- Competition in generic drugs could impact pricing.
- Currency fluctuations may influence export revenues.
- Product concentration risks may affect earnings stability.
Today’s Share Performance
Natco Pharma shares traded at Rs 888.80, up 0.51 percent from the previous close of Rs 884.30. The stock touched an intraday high of Rs 913.40 and a low of Rs 884.80. Trading volume stood at 7.58 lakh shares, while traded value reached approximately Rs 68.34 crore. The company's market capitalisation was Rs 15,919.29 crore and the stock traded at a P/E ratio of 11.55.
Summary
Natco Pharma traded modestly higher during Tuesday's session, although the stock remains well below its 52-week high recorded in May 2026. While short-term weekly performance has outpaced the Nifty 500, the stock has declined sharply over the past month. Investors may continue monitoring regulatory developments, product performance, competitive pressures and earnings trends within the pharmaceutical sector.
FAQs
Q: How did Natco Pharma shares perform today?
A: The stock gained 0.51 percent and traded at Rs 888.80 during Tuesday's session.
Q: How far is Natco Pharma from its 52-week high?
A: The stock remains below its 52-week high of Rs 1,226.80 recorded in May 2026.
Q: What is Natco Pharma's current P/E ratio?
A: Natco Pharma is trading at a price-to-earnings ratio of 11.55 based on exchange data.